深度镇静下射频房颤导管消融中经鼻高流量氧疗与标准经鼻低流量氧疗比较:单中心随机对照试验
本研究为单中心随机对照试验,计划纳入每组94例在深度镇静下接受择期射频房颤导管消融的成人患者,比较经鼻高流量氧疗(HFNC)与经鼻低流量氧疗(LFNC)对最低血氧饱和度的影响,并评估多种镇静与氧疗相关次要结局。研究假设HFNC较LFNC能预防低氧血症和血氧饱和度下降,注册号为NCT04842253。
要点
- 拟比较深度镇静下射频房颤消融中HFNC与LFNC对最低血氧饱和度的影响。
- 主要结局为最低血氧饱和度,次要结局包括低氧持续时间及SpO2低于90%超过60秒的发生率等。
- 研究假设HFNC较LFNC能预防低氧血症和血氧饱和度下降。
核心结论
- 研究假设HFNC在深度镇静患者中较标准LFNC在血氧饱和度下降发生率方面更优,但原文为试验方案,尚未报告结果。
研究设计与样本
- 单中心随机对照试验,干预组为HFNC,对照组为LFNC。
- 计划每组纳入94例在深度镇静下接受择期射频房颤导管消融的成人患者。
- 研究在射频房颤导管消融的2天住院期间进行,患者可在治疗后第一周填写问卷。
- 试验注册号为ClinicalTrials.gov NCT04842253,注册日期为2021年4月4日。
主要发现
- 原文为试验方案,未报告主要结局和次要结局的结果。
关键数值与推荐
- 主要结局为最低血氧饱和度(SpO2)。
- 次要结局包括最低SpO2的持续时间、两个方向上的氧疗交叉转换、SpO2低于90%持续超过60秒的发生率、不良镇静事件、HFNC的不良反应、平均CO2、峰值CO2以及患者对氧疗的体验。
临床怎么用
- 原文为试验方案,未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To our knowledge, there are few trials studying the effect of high-flow nasal cannula (HFNC) during deep sedation. Our hypothesis is that high-flow nasal cannula (HFNC) will prevent hypoxemia and desaturation as compared to low-flow nasal cannula (LFNC) during prolonged deep sedation in patients with atrial fibrillation undergoing radiofrequency catheter ablation (RFCA). METHODS: A single-centre, randomised controlled trial with HFNC as the intervention and LFNC as the control group. A total of 94 adult patients per group undergoing elective radiofrequency atrial fibrillation catheter ablation under deep sedation. will be included. The primary outcome is the lowest oxygen saturation (SpO2). Secondary outcomes are as follows: the duration of lowest SpO2, cross over from oxygen therapy in both directions, incidence of SpO2 below 90% > 60 seconds, adverse sedation events, adverse effects of HFNC, mean CO2, peak CO2 and patients experience with oxygen therapy. The study will take place during the 2-day admission period for RFCA. Patients can fill out their questionnaires in the first week after treatment. DISCUSSION: HFNC is increasingly used as a technique for oxygen delivery in procedural sedation and analgesia. We hypothesise that HFNC is superior to the standard treatment LFNC in patients under deep sedation with respect to the incidence of desaturation. To our knowledge, there are no adequately powered clinical trial studies on the effects of HFNC in prolonged deep sedation. TRIAL REGISTRATION: ClinicalTrials.gov NCT04842253. Registered on 04 April 2021.
引用
- Homberg MC, Bouman EA, Linz D, et al. High-flow nasal cannula versus standard low-flow nasal cannula during deep sedation in patients undergoing radiofrequency atrial fibrillation catheter ablation: a single-centre randomised controlled trial. Trials. 2022. PMID: 35534903. doi:10.1186/s13063-022-06362-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。